First Tracks Biotherapeutics raises $200M
- Issued 6,106,870 shares at $32.75 each
- Expected to close on Oct 19, 2026
- Gross proceeds of $200M before fees
TRAX
First Tracks Biotherapeutics, Inc. SEC filings
Every EDGAR filing for First Tracks Biotherapeutics, Inc. (TRAX), newest first, with AI summaries and stories.
- Ticker
- TRAX
- CIK
- 2091349
- Sector
- Biotech and pharma
- Latest filing
- 3d
Next: earnings expected ~May 14 · 10-Q expected ~May 14 (deadline May 17)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXVLIVE ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXVLIVE First Tracks Biotherapeutics updates investor presentation
- Filed Form 8-K on 2026-10-13
- Updated corporate investor presentation on 2026-10-12
- Issued press release with positive Phase 1b data for ANB033
ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVLIVE John A Orwin, insider filing for TRAXV
John A Orwin, reporting
ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVLIVE J. Anthony Ware, insider filing for TRAXV
J. Anthony Ware, reporting
ROUTINE144First Tracks Biotherapeutics, Inc.TRAXVLIVE J. Anthony Ware, planned sale of TRAXV shares
J. Anthony Ware, reporting
ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVLIVE 3 insider filings
Daniel Faga, insider filing for TRAXV
Show all 3
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
Daniel Faga, reporting
ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVLIVE Ownership stake disclosure by TCG Crossover GP II, LLC
TCG Crossover GP II, LLC, filed by
ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVLIVE Ownership stake disclosure by Sirenia Capital Management LP
Sirenia Capital Management LP, filed by
ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVLIVE Ownership stake disclosure by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC, filed by
ROUTINE424B3First Tracks Biotherapeutics, Inc.TRAXVLIVE NOTABLE10-QFirst Tracks Biotherapeutics, Inc.TRAXVLIVE ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXVLIVE ROUTINE3/AFirst Tracks Biotherapeutics, Inc.TRAXVLIVE 3 insider filings
Paul F. Lizzul, new insider at TRAXV (amended)
Show all 3
- 3/ANew insider at TRAXV (amended)
- 3/ANew insider at TRAXV (amended)
- 3/ANew insider at TRAXV (amended)
Paul F. Lizzul, reporting
ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVLIVE Ownership stake disclosure by FMR LLC
FMR LLC, filed by
ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVLIVE 3 insider filings
Benjamin Stone, insider filing for TRAXV
Show all 3
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
Benjamin Stone, reporting
ROUTINESCHEDULE 13GFirst Tracks Biotherapeutics, Inc.TRAXVLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXVLIVE ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVLIVE 6 insider filings
J. Anthony Ware, insider filing for TRAXV
Show all 6
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
J. Anthony Ware, reporting
ROUTINE4/AFirst Tracks Biotherapeutics, Inc.TRAXVLIVE 6 insider filings
Dennis M Fenton, insider filing for TRAXV (amended)
Show all 6
- 4/AInsider filing for TRAXV (amended)
- 4/AInsider filing for TRAXV (amended)
- 4/AInsider filing for TRAXV (amended)
- 4/AInsider filing for TRAXV (amended)
- 4/AInsider filing for TRAXV (amended)
- 4/AInsider filing for TRAXV (amended)
Dennis M Fenton, reporting
ROUTINE424B3First Tracks Biotherapeutics, Inc.TRAXVLIVE ROUTINE424B3First Tracks Biotherapeutics, Inc.TRAXVLIVE NOTABLE10-QFirst Tracks Biotherapeutics, Inc.TRAXVLIVE ROUTINE8-KFirst Tracks Biotherapeutics, Inc.TRAXVLIVE ROUTINE4First Tracks Biotherapeutics, Inc.TRAXVLIVE 10 insider filings
Rita Jain, insider filing for TRAXV
Show all 10
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
- 4Insider filing for TRAXV
Rita Jain, reporting
ROUTINEEFFECTFirst Tracks Biotherapeutics, Inc.TRAXVLIVE